. 2022 Jan 17;11:704999. doi: 10.3389/fonc.2021.704999
Copyright © 2022 Wang, Chen, Liu, Li and Dai
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 1.
The development of CRISPR/Cas9 system and cancer immunotherapy.